NWBO can sort out their financial position (upcoming financing / work out of the toxic stuff) BUT IMUC have to live with
+inferior technology (can only treat HLA a1/a2 - 50% of population)
+questionable patent position
+still only in Phase 2 rather than NWBO's Phase 3.
+Single Continent trial rather than 2 continent Trial (NWBO) with compassionate use patients
Apart from that it's fairly equal.....LOL
You clearly don't understand the drug dev process. They can have 1000 sites open...this requires very little money or effort on the part of either NW or the sites. Once IRB approval and other pieces in place, the sites can go about their business of seeing patients and running other studies until they see funding and manufactured drug substance are available and subjects have been recruited...even enrolled subjects aren't necessarily dosed, if no funding or manufactured material is available...it just means the potential subject has met study entry criteria...RJ
One could speculate that they did so because they know they don't have enough funding to go the normal process so are rolling the dice and gambling they can 1) entice enough funding for PIII to run the study and 2) hit a home run even without the critical PII info on optimizing dose, dose interval, and study subject population.
The only thing comical here is you. How about asking yourself WHY they don't list enrollment numbers. How about that? Do you honestly think for one second if the enrollment was going well LIKE IN IMUC'S CASE they WOULDN'T say? They keep their shareholders in the dark. That is a bad sign.
RJ....because NWBO has not provided enrollment numbers with end of Q2012 press release had 42 sites open for enrollment with almost half as of the end of 2011 and you actaully believe they have not a patient enrolled????????? You are naive and should stop posting this nonsense about having no funds as well. Your posts are actually comical!
I'll provide info regarding my points. Here's a direct quote from NWBO press release of 5/1/2012:
"To date, 24 of the 30 clinical trial sites in Germany have already been selected
and are in varying stages of qualification and preparation."
As of May 1, ZERO subjects enrolled or dosed in Germany/ A more recent press release indicates that the manufacturing site has been approved, so they'll need ramp up time, then enrollment can start.
Where's your links?